We tested the activity of the marine nutraceutical CL-1222 added with a coenzyme Q10 (CoQ10)-luteinselenium component (Celergen Ò , Laboratoires-Dom, Switzerland) to protect human fibroblasts against ultraviolet A (UVA)-induced photoaging. Cells obtained from 22-to 39-year-old healthy donors were pretreated with CL-1222 before UV irradiation, as compared with same quantity of the CoQ10-lutein-selenium component. As compared to untreated control, UVA-irradiated samples exhibited a significant increase of secreted matrix metalloproteinase-1 (MMP-1) ( p < 0.001) with over four-fold MMP-1 upregulation ( p < 0.001). Samples treated with CL-1222, but not with the CoQ10-lutein-selenium component, showed a significant decrease of MMP-1 secretion ( p < 0.01) and expression decrease ( > 60%, p < 0.01) with > 54% elastase activity inhibition ( p < 0.01). This preliminary study shows that such marine nutraceuticals can significantly protect against UV-irradiation irrespective of the CoQ10-lutein-selenium component with a specific protective gene expression modulation amenable to novel clinical applications.
Introduction

L
ong-wavelength ultraviolet A (UVA) radiation (320-400 nm) comprises over 95% of the total UV radiation that reaches the surface of the earth and penetrates deeply into human skin. UV radiation is one of the causative factors of DNA damage and inflammatory responses and induces various skin lesions, being a well-established epidemiological risk factor for photoaging and photocarcinogenesis. 1, 2 Indeed, a lifetime of acute exposures with accumulation of invisible solar scars will eventually lead to evident solar scars, causing the characteristic wrinkling of photodamaged skin. 3 Moreover, the matrix metalloproteinases (MMP) production and subsequent extracellular matrix (ECM) alteration have been observed in premature skin aging and in aged skin. Thus, it has been ascertained that UV causes photoaging by generating reactive oxygen species (ROS), subsequently triggering a cascade of signaling mechanisms. 4 These are then targeted to eventually cause a decrease of collagen and an increase of MMP, inflammation, epidermal DNA damage, and apoptosis.
In this context, elastase also plays a critical role in inflammatory processes, 5 and this enzyme has drawn a great deal of attention, mainly because of its reactivity and nonspecificity.
Indeed, elastase is able to attack all major connective tissue matrix proteins, including elastin, proteoglycans, collagen, and keratins. Because this elastic fiber is easily degraded by elastase secretion and activation caused by exposure to UV or ROS, the inhibition of elastase activity represents a useful approach to protect against skin aging. Recently, a number of marine compounds have gained popularity for their cytoprotective and membrane-stabilizing effects. 6 Thus, the aim of this study was to test the activity of a marine nutraceutical CL-1222 (containing DNA, collagen elastin, and protein extracts together with grape skin extract, coenzyme Q10 (CoQ10), lutein, and selenium; Celergen Ò , Laboratoires Dom AVMM, Switzerland) to exert a significant protection against UVAinduced photoaging of human fibroblasts.
Materials and Methods
Full-thickness human skin biopsies were obtained from sun-protected buttock skin of 22-to 32-year-old healthy donors by punch biopsy. Skin samples were incubated in wells of a 24-well dish (one tissue piece per 500 lL of culture medium). Fibroblasts from the biopsy specimens were cultured in Dulbecco modified Eagle medium (DMEM) containing penicillin (100 UI/mL), streptomycin (100 mg/ dL), L-glutamine (4 mM) and supplemented with heatinactivated fetal calf serum (FCS) at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . Cells were grown to confluence, harvested by trypsinization at 37°C, washed with culture medium, resuspended with 20 mM phosphate buffer, and then sonicated to obtain the cell homogenate. The cells were then pretreated with CL-1222 or the equivalent content of the CoQ10-lutein-selenium component (B treatment) for 24 hr before UV irradiation. After pretreatment, cells were washed with phosphate-buffered saline (PBS) and then irradiated with UV in PBS.
Cytotoxicity assay in a monolayer culture and test
Part of the outgrown fibroblasts were trypsinized and grown in DMEM supplemented with 10% FBS at 37°C in an incubator with 5% CO 2 and 95% humidified air. The culture medium was changed every 3 days. Then, the monolayer culture was checked after incubation with increasing concentrations of CL-1222 (50-300 l/mL) before proceeding with the study.
Zymography analysis of MMP-1 secretion
Fluorescein isothiocyanate (FITC)-labeled calf skin type I collagen (50 lL, Elastin Products Co.) was coated onto glass slides. Cryostat skin sections (5 lm) were placed on top of the collagen coating and incubated for 24 hr in a sealed, humidified chamber at 37°C. To detect the activity of secreted matrix metalloproteinase-1 (MMP-1) in culture supernatants, zymography was performed in 10% polyacrylamide gels containing gelatin. Samples were suspended in loading buffer [10% sodium dodecyl sulfate (SDS), 25% glycerol, 0.25 M Tris, pH 6.8, and 0.1% Bromophenol Blue], and, without previous denaturation, run on 10% SDS-polyacrylamide gels that contained 0.5 mg/mL gelatin. After electrophoresis, gels were washed to remove SDS and incubated for 30 min at room temperature in renaturing buffer (50 mM Tris, 5 mM CaCl 2 , 0.02% NaN 3 , and 1% Triton X-100). The gels were then incubated for 24 hr at 37°C in developing buffer (50 mM Tris, pH 7.8, 0.15 M NaCl, 5 mM CaCl 2 , and 1% Triton X-100). Gels were then stained with Coomassie Brilliant Blue G-250 (Sigma Chemical Company, St Louis, MO) for 10 min and destained with 10% acetic acid for 1 hr to identify the bands of proteolytic activity. Inhibition assays were performed by adding 10 nM Ro32-3555 (Tocris Bioscience) to collagenase buffer prior to incubation. For quantification of the bands, the gels were scanned by an image-analysis system and analyzed with image software (Leica QWin software).
Elastase activity inhibition
To evaluate the inhibition of elastase activity, the amount of released p-nitroaniline, which was hydrolyzed from the substrate, N-succinyl-Ala-Ala-Ala-p-nitroanilide, by elastase, was read with a maximum absorbance at 410 nm. In brief, 1.015 mM N-succinyl-Ala-Ala-Ala-p-nitroanilide was prepared in a 0.1232 M Tris-Cl buffer (pH 8.0), and this solution (1,300 mL) was added to the stock sample (100 mL). Each sample solution was diluted to final concentrations of 50 lg/mL. The solutions were vortexed and preincubated for 10 min at 25°C before an elastase (0.0375 U/mL) stock solution (100 mL) was added. After vortexing, each solution was placed in a water bath for 10 min at 25°C, and the absorbance was measured at 410 nm.
Assay of MMP-1 expression by RT-PCR
Assay was accomplished by real-time quantitative b AU2 PCR and RT-PCR. Total RNA was isolated from human fibroblasts using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA) and disrupted by a rotating blade homogenizer (Omni International). Total RNA (1-2 mg) was reverse transcribed into cDNA using a first-strand cDNA synthesis kit (MBI Fermentas; Vilnius, Lithuania). Quantitation of procollagen a1(I), MMP-1, and endogeneous reference 36B4 cDNA was performed using a fluorescence detection method, the 7500 Real-time PCR System. Sequence-specific PCR primer sets and the TaqMan MGB probe were purchased from Applied Biosystems. For real-time PCR, cycling conditions were 50°C for 2min, 95°C for 10min, followed by 40 cycles at 95°C for 15 sec and 60°C for 1 min. Data were analyzed using the 2 -ddCt (2-DDCt) methods
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; the data were presented as the fold change in gene expression normalized to an endogenous reference gene and relative to the untreated control sample. For the untreated control sample, DDCT equals 0 and 2j equals 1, so that the fold change in gene expression relative to the untreated control equals 1, by definition. For the treated samples, evaluation of 2-DDCT indicates the fold change in expression relative to the untreated control. For semiquantitative RT-PCR, oligonucleotide primers were as follows: human MMP-1 sense primer, 5¢-ATT CTA CTG ATA TCG GGG CTT TGA-3¢; human MMP-1 antisense primer, 5¢-ATG TCC TTG GGG TAT CCG TGT AG-3¢. After pre-denaturation at 94°C for 3 min, each cycle of PCR amplification consisted of denaturation at 94°C for 30 sec, annealing at 60°C for 30 sec, and elongation at 72°C for 30 sec; 21 cycles were performed for 36B4 and procollagen a1(I), 24 cycles for MMP-1 and interleukin-6 (IL-6), and 30 cycles for cyclooxygenase-2 (COX-2), after a final extension at 72°C for 5 min. PCR products were resolved on 2.0% agarose gels, followed by quantification with a densitometry analysis (TINA, Raytest, Straubenhardt, Germany) of bands (relative density normalized to 36B4).
Results
Cytotoxicity assay
Cytotoxicity assay in a monolayer culture was checked before proceeding with the study, and CL-1222 was found devoid of any cell damaging effect at any dosage in the medium.
Zymography analysis of MMP-1 secretion
As compared to untreated control, UVA-irradiated samples exhibited a significant increase of secreted MMP-1 (115 ng/mL vs. 22 ng/mL, p < 0.001). Samples treated with CL-1222, but not with the B treatment, showed a statistically significant decrease of MMP-1 secretion (63 ng/mL, p < 0.01 vs. UVA alone).
Elastase activity inhibition
Samples treated with CL-1222, but not with B treatment, showed a statistically significant ( > 54%) elastase activity inhibition ( p < 0.01).
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Assay of MMP-1 expression
As compared to untreated control, UVA-irradiated samples exhibited two-to three-fold increase of MMP-1-upregulation ( p < 0.001). Samples treated with CL-1222, but not with the B treatment, showed a statistically significant decrease of MMP-1 expression ( > 60%, p < 0.01 vs. UVA alone).
Discussion
Skin is the largest human organ and is the only organ directly exposed to UV irradiation. 8, 9 UV radiation is one of the causative factors of DNA damage and inflammatory responses and induces a range of skin lesions, being a wellestablished epidemiological risk factor for photoaging and photocarcinogenesis. MMP production and subsequent ECM alteration are distinctive features in photoaged skin. MMPs are a family of zinc-dependent proteases that can degrade all components of the extracellular matrix. 10 MMP activity is tightly regulated at the level of transcription and activation by proteolytic cleavage and is specifically inhibited by tissue inhibitor of metalloproteinases. 11 Excessive MMP activity is implicated in diverse illnesses characterized by ECM destruction. Indeed, UV-induced MMPs show proteolytic activity to degrade skin matrix proteins, which impairs the structural integrity of the dermis. 12 In our study we showed that CL-1222 enabled a significant inhibition of UV-induced MMP transcription, and this was paralleled by a drop in the release of MPP-1 in the medium. When the matrix is not adequately repaired, MMPmediated collagen damage tends to accumulate with each consecutive UV exposure, and such cumulative collagen damage ends up being a major contributor to the phenotype of photoaged human skin. In this regard, another interesting finding of our study was the ability of CL-1222 to also markedly inhibit elastase activity. This holds some interest when considering that elastase is the only enzyme that is capable of degrading by hydrolysis elastin, an insoluble and essential elastic fibrous protein for connective tissues and collagen. 13 We did not address the specific mechanisms of CL-1222 in this study, but a beneficial modulation of lipid metabolism is likely to be advocated for as this has been recently shown to be deranged by UV.
14 This proved to be significantly better than its own antioxidant component per se, although these compounds have been recently shown to be of some effectiveness. 15 Taken together, these preliminary ex vivo studies show that such a marine nutraceutical extract is able to provide a significant protection against UV irradiation. This action, unrelated to the CoQ10-lutein-selenium component, seems to exert a specific protective gene expression modulation amenable to novel clinical application strategies, also given its safety profile, whereas other nutraceuticals generally regarded as safe have recently raised very serious concerns. 
